There were 163 press releases posted in the last 24 hours and 437,690 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Summit Awarded Additional $12 Million by BARDA for Phase 3 Development Programme of Ridinilazole for the Treatment of C. difficile Infection

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image